Thomas Sciascia Trevi Therapeutics, Inc. (TRVI) insider trading activity

TRVI Quotes by TradingView

Thomas Sciascia is Chief Scientific Officer of Trevi Therapeutics, Inc.. Currently has a direct ownership of 221,373 shares of TRVI, which is worth approximately $1.34 Million. The most recent transaction as insider was on Mar 25, 2025, when has been sold 2,631 shares (Common Stock) at a price of $6.6 per share, resulting in proceeds of $17,364. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K
0.48% 3M change
n/a 12M change
Total Value Held $1.34 Million

THOMAS SCIASCIA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2025
SELL
Open market or private sale
$17,364 $6.6 p/Share
2,631 Reduced 1.17%
221,373 Common Stock
Mar 25 2025
BUY
Exercise of conversion of derivative security
$3,762 $1.43 p/Share
2,631 Added 1.16%
224,004 Common Stock
Aug 19 2024
SELL
Open market or private sale
$48,828 $2.96 p/Share
16,496 Reduced 6.97%
220,315 Common Stock
Aug 19 2024
BUY
Exercise of conversion of derivative security
$23,589 $1.43 p/Share
16,496 Added 6.51%
236,811 Common Stock
Aug 16 2024
SELL
Open market or private sale
$51,501 $2.76 p/Share
18,660 Reduced 7.81%
220,315 Common Stock
Aug 16 2024
BUY
Exercise of conversion of derivative security
$26,683 $1.43 p/Share
18,660 Added 7.24%
238,975 Common Stock
Aug 15 2024
SELL
Open market or private sale
$35,558 $2.79 p/Share
12,745 Reduced 5.47%
220,315 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
$18,225 $1.43 p/Share
12,745 Added 5.19%
233,060 Common Stock
Aug 14 2024
SELL
Open market or private sale
$275 $2.75 p/Share
100 Reduced 0.05%
220,315 Common Stock
Aug 14 2024
BUY
Exercise of conversion of derivative security
$143 $1.43 p/Share
100 Added 0.05%
220,415 Common Stock
May 29 2024
SELL
Open market or private sale
$136,088 $2.55 p/Share
53,368 Reduced 19.93%
214,433 Common Stock
May 29 2024
BUY
Exercise of conversion of derivative security
$129,985 $2.19 p/Share
59,354 Added 18.14%
267,801 Common Stock
TS

Thomas Sciascia

Chief Scientific Officer
New Haven, CT

Track Institutional and Insider Activities on TRVI

Follow Trevi Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVI shares.

Notify only if

Insider Trading

Get notified when an Trevi Therapeutics, Inc. insider buys or sells TRVI shares.

Notify only if

News

Receive news related to Trevi Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRVI